Lubor Gaal
Direttore Finanziario/CFO presso CIRCIO HOLDING ASA
Patrimonio netto: 1 $ in data 31/03/2024
Posizioni attive di Lubor Gaal
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| TREX WIND-DOWN, INC. | Direttore/Membro del Consiglio | 19/08/2020 | - |
| Independent Dir/Board Member | 19/08/2020 | - | |
| CIRCIO HOLDING ASA | Direttore Finanziario/CFO | 07/03/2022 | - |
| Public Communications Contact | - | - |
Storia della carriera di Lubor Gaal
Precedenti posizioni note di Lubor Gaal
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/2006 | 01/01/2015 |
| BAYER AG | Corporate Officer/Principal | - | - |
Locust Walk Partners LLC
 Locust Walk Partners LLC Miscellaneous Commercial ServicesCommercial Services Locust Walk Partners LLC provides commercial supporting and advisory services. The firm involves in securities-related transactions for clients, including mergers and acquisitions, private placements & mezzanine financings and partnerships involving equity investments. The company was founded by Geoff Meyerson and Joseph Mohr in 2008 and is headquartered in Boston, MA. | Corporate Officer/Principal | 01/07/2018 | - |
| ALMIRALL, S.A. | Corporate Officer/Principal | - | - |
Neuro3D SA
 Neuro3D SA Pharmaceuticals: OtherHealth Technology Neuro3d SA develops pharmaceutical products to treat the central nervous system. Neuro3d has a full pipeline of innovative compounds with new mechanisms of action that have the potential to overcome the limitations of current drug therapies. It leads compound, the atypical antipsychotic ocaperidone, is being investigated in two international double-blind Phase II trials for treatment of schizophrenia. The company was founded in November 2000 and is headquartered in Mulhouse, France. | Vendite & Marketing | - | - |
Formazione di Lubor Gaal
| University of Sussex | Undergraduate Degree |
| University of California | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
| Francia | 2 |
| Regno Unito | 2 |
Posizioni
| Corporate Officer/Principal | 4 |
| Sales & Marketing | 1 |
| Director/Board Member | 1 |
Settori
| Health Technology | 7 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 5 |
|---|---|
| TREX WIND-DOWN, INC. | Health Technology |
| ALMIRALL, S.A. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| BAYER AG | Health Technology |
| CIRCIO HOLDING ASA | Health Technology |
| Aziende private | 2 |
|---|---|
Neuro3D SA
Neuro3D SA Pharmaceuticals: OtherHealth Technology Neuro3d SA develops pharmaceutical products to treat the central nervous system. Neuro3d has a full pipeline of innovative compounds with new mechanisms of action that have the potential to overcome the limitations of current drug therapies. It leads compound, the atypical antipsychotic ocaperidone, is being investigated in two international double-blind Phase II trials for treatment of schizophrenia. The company was founded in November 2000 and is headquartered in Mulhouse, France. | Health Technology |
Locust Walk Partners LLC
Locust Walk Partners LLC Miscellaneous Commercial ServicesCommercial Services Locust Walk Partners LLC provides commercial supporting and advisory services. The firm involves in securities-related transactions for clients, including mergers and acquisitions, private placements & mezzanine financings and partnerships involving equity investments. The company was founded by Geoff Meyerson and Joseph Mohr in 2008 and is headquartered in Boston, MA. | Commercial Services |
- Borsa valori
- Insiders
- Lubor Gaal
- Esperienza
